Volume 59, Issue 4 p. 627-633
Original Article

UCHL-1 is not a Parkinson's disease susceptibility gene

Daniel G. Healy MRCPI

Corresponding Author

Daniel G. Healy MRCPI

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, United KingdomSearch for more papers by this author
Patrick M. Abou-Sleiman PhD

Patrick M. Abou-Sleiman PhD

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Search for more papers by this author
Juan P. Casas MD

Juan P. Casas MD

Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, University College London, London, United Kingdom

Search for more papers by this author
Kourosh R. Ahmadi PhD

Kourosh R. Ahmadi PhD

Department of Biology, University College London, London, United Kingdom

Search for more papers by this author
Timothy Lynch FRCPI

Timothy Lynch FRCPI

Department of Neurology, Mater Misericordiae University Hospital, Dublin, Ireland

Search for more papers by this author
Sonia Gandhi MRCP

Sonia Gandhi MRCP

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Search for more papers by this author
Miratul M. K. Muqit MRCP

Miratul M. K. Muqit MRCP

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Search for more papers by this author
Thomas Foltynie MRCP

Thomas Foltynie MRCP

Cambridge Centre for Brain Repair, University of Cambridge, Cambridge

Search for more papers by this author
Roger Barker FRCP, PhD

Roger Barker FRCP, PhD

Cambridge Centre for Brain Repair, University of Cambridge, Cambridge

Search for more papers by this author
Kailash P. Bhatia MD, FRCP

Kailash P. Bhatia MD, FRCP

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London

Search for more papers by this author
Niall P. Quinn MD, FRCP

Niall P. Quinn MD, FRCP

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London

Search for more papers by this author
Andrew J. Lees MD, FRCP

Andrew J. Lees MD, FRCP

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Reta Lila Weston Institute for Neurological Studies, University of London, London

Search for more papers by this author
J. Mark Gibson MD, FRCP

J. Mark Gibson MD, FRCP

Department of Neurology, Belfast City Hospital, Belfast, United Kingdom

Search for more papers by this author
Janice L. Holton MD, PhD

Janice L. Holton MD, PhD

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Search for more papers by this author
Tamas Revesz MD

Tamas Revesz MD

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Search for more papers by this author
David B. Goldstein PhD

David B. Goldstein PhD

Department of Biology, University College London, London, United Kingdom

Search for more papers by this author
Nicholas W. Wood PhD, FRCP, FMedSci

Nicholas W. Wood PhD, FRCP, FMedSci

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

Search for more papers by this author
First published: 31 January 2006
Citations: 91

Abstract

Objective

The UCHL-1 gene is widely cited as a susceptibility factor for sporadic Parkinson's disease (PD). The strongest evidence comes from a meta-analysis of small studies that reported the S18Y polymorphism as protective against PD, after pooling studies of white and Asian subjects. Here, we present data that challenge this association.

Methods

In a new large case–control study in white individuals (3,023 subjects), the S18Y variant was not protective against PD under any genetic model of inheritance. Similarly, a more powerful haplotype-tagging approach did not detect other associated variants.

Results

Finally, in an updated S18Y-PD meta-analysis (6,594 subjects), no significant association was observed under additive, recessive, or dominant models (odds ratio = 1.00 [95% confidence interval: 0.74–1.33]; odds ratio = 1.01 [95% confidence interval: 0.76–1.35]; and odds ratio = 0.96 [95% confidence interval: 0.86–1.08], respectively), and a cumulative meta-analysis showed a trend toward a null effect.

Interpretation

Based on the current evidence, the UCHL-1 gene does not exhibit a protective effect in PD. Ann Neurol 2006

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me